Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
17 Nov, 2022 | 12:17h | UTCCommentary: Inclisiran and Cardiovascular Events – American College of Cardiology
Commentary on Twitter
https://twitter.com/ESC_Journals/status/1592113799481692162